#United States #Dallas #Vascular Health #Koya Medical #Dayspring

Koya Medical to Present at May 2026 Investor Conferences

Koya Medical, an innovative force in the medical technology sector specializing in vascular health, has made headlines with its upcoming participation in significant investor conferences scheduled from May 19 to May 21, 2026. This participation underscores the company’s commitment to advancing patient-centered solutions and enhancing public awareness around vascular health issues that affect millions.

Conference Details

The two notable conferences where Koya will be presenting include the 2026 RBC Capital Markets Global Healthcare Conference in New York City, scheduled for May 20 at 10:00 AM ET. In addition, they will participate in the 2026 Wells Fargo Virtual Private MedTech Symposium. During these sessions, Koya's CEO, Andy Doraiswamy, and CFO, Damian Rippole, will shed light on the company's ongoing commercial momentum and its robust product portfolio, which includes the Dayspring® non-pneumatic compression treatment for chronic edema.

Advancements in Vascular Health

Founded in 2018 and headquartered in Dallas, Texas, Koya Medical is on a mission to redefine vascular health solutions. The company was established with the intent to address serious medical conditions affecting vascular function, informed by the personal experiences of its founders with vascular disease. They aim to close existing treatment gaps through innovative solutions that prioritize patient care.

One of Koya's standout products is the FDA-cleared Dayspring treatment system. This non-invasive, patient-friendly device offers relief to individuals suffering from chronic conditions. Its effectiveness and accessibility are paramount in a healthcare landscape that demands modern, evidence-based solutions, particularly as more than 35 million Americans grapple with venous and lymphatic diseases. Lack of treatment not only compromises mobility but also diminishes the quality of life for many individuals affected by these conditions.

Why Vascular Health is Critical

Vascular health is a critical aspect of overall well-being, yet it often does not receive the attention it deserves. The diseases associated with vascular dysfunction can exhibit silent symptoms leading to severe health outcomes if not properly managed. As the population ages, the urgency for effective and scalable treatment options becomes even more pressing. Koya Medical’s commitment to providing contemporary solutions reflects a significant advancement in this field.

The upcoming investor conferences not only allow Koya to showcase its progress but also serve as a platform for them to engage with stakeholders, investors, and industry experts. Sharing updates on ongoing clinical research related to its vascular pipeline will enhance transparency and encourage further investment in innovative healthcare solutions that assist patients in their recovery and management processes.

Conclusion

As Koya Medical prepares for its presentations in May 2026, the excitement continues to build around their role in transforming vascular health care. Their mission to deliver effective, patient-centered solutions resonates deeply with both healthcare professionals and patients alike, highlighting the need for continued innovation in the medical technology space.

To stay updated on Koya Medical's journey and for more information about their pioneering interventions, you can follow their developments via their official website at www.koyamedical.com or connect with them on LinkedIn.

In summary, Koya Medical is not just shaping the future of vascular health—it is driving a crucial change that can drastically improve millions of lives affected by vascular diseases.